Stock Events

Stock Events

Candel Therapeutics (CADL) Q3 2024 Earnings

13AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-0.74

-0.49

-0.25

0

Details

Expected EPS

N/A

Actual EPS

-0.74

Surprise EPS

-0.74

Surprise Percent

+∞%

Description

Candel Therapeutics (CADL) has reported earnings of -0.74 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.